Female. Born 1962. British.

Senior Vice President of Finance, AstraZeneca plc (UK). 

Background

• Joined the Board of Directors in 2019. Member of the Audit Committee (Chair).
• Holds no H+H shares, with no changes in her holding in 2023.
• Independent as defined in the Danish Recommendations on Corporate Governance.
• Extensive experience within strategic and operational finance and international experience in change management, financial oversight and control, governance and risk frameworks as well as international talent development. 

Other management positions and directorships
N/A

Return to Management & Board